View Older Stories View More Recent Stories

Sep 25, 2019 07:00AM Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
Sep 4, 2019 06:58AM Citius Pharmaceuticals (CTXR) Announces Change to Primary Endpoint In Mino-Lok Phase 3 Study
Sep 4, 2019 06:55AM Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study
Aug 29, 2019 08:00AM Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.
Aug 22, 2019 07:13AM Citius Pharmaceuticals (CTXR) PT Lowered to $1.65 at H.C. Wainwright
Jul 30, 2019 08:00AM Citius Provides Developmental Plans for Mino-Wrap
May 13, 2019 08:47AM Citius Pharmaceuticals' Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris
May 1, 2019 08:00AM Citius Pharmaceuticals to Present at the ThinkEquity Conference
Apr 30, 2019 09:45AM Citius Pharmaceuticals Presents Data on Mino-Lok® Showing 98% Clinical Efficacy
Apr 4, 2019 08:30AM Citius Pharmaceuticals Successfully Raises $5.3 Million
Apr 1, 2019 09:03AM Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market
Apr 1, 2019 09:00AM Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market
Feb 6, 2019 01:11PM Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center
Jan 25, 2019 08:00AM Citius Pharmaceuticals to Present at NobleCon15 Investor Conference
Jan 8, 2019 09:00AM Citius Licenses Mino-Wrap From MD Anderson Cancer Center
Jan 4, 2019 10:45AM Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference
Dec 19, 2018 09:52AM Citius Pharmaceuticals (CTXR) Reports Update on Mino-Lok and CITI-002
Dec 19, 2018 09:45AM Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002
Nov 30, 2018 08:00AM Citius Pharmaceuticals to Present at the 11th Annual LD Micro Main Event
Oct 25, 2018 08:00AM Citius Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
Oct 23, 2018 08:00AM Citius Reports On Activities During Infectious Disease Week 2018
Sep 27, 2018 08:00AM Citius Announces The Publication Of European Patent For Mino-Lok®
Sep 25, 2018 08:00AM Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
Aug 15, 2018 08:00AM Citius Pharmaceuticals Successfully Raises $10 Million
Aug 13, 2018 05:00PM Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
Aug 9, 2018 06:23AM Citius Pharmaceuticals (CTXR) Prices 7.843M Share Offering at Approx. $10M
Aug 9, 2018 06:00AM Citius Announces Pricing of $10.0 Million Underwritten Offering Priced At-the-Market
Jul 24, 2018 08:04AM Citius Pharmaceuticals (CTXR) Granted Notice Of Allowance from USPTO on Advanced Stability Patent Application For Mino-Lok
Jul 24, 2018 08:00AM Citius Announces The Notice Of Allowance From The USPTO On The Advanced Stability Patent Application For Mino-Lok®
Jul 13, 2018 10:48AM Citius Announces Key Addition to its Scientific Advisory Board
Jul 9, 2018 08:10AM Citius Pharmaceuticals (CTXR) Announces Clinical Update And Progress of Mino-Lok Phase 3 Trial
Jul 9, 2018 08:00AM Citius Provides Clinical Update And Progress Of The Mino-Lok® Phase 3 Trial
Jun 19, 2018 08:00AM Citius Announces United States Patent & Trademark Office Registered the Company's Mino-Lok® Trademark
Mar 29, 2018 08:02AM Citius Pharmaceuticals (CTXR) Announces $2 Million Registered Direct Offering Priced At-the-Market
Mar 29, 2018 08:00AM Citius Announces $2.0 Million Registered Direct Offering Priced At-the-Market
Mar 6, 2018 08:00AM Citius Reports Progress in Hemorroid Treatment Program
Feb 15, 2018 08:08AM Citius Pharmaceuticals (CTXR) Reports Enrollment Of First Patient In The Mino-Lok Phase 3 Trial
Feb 15, 2018 08:00AM Citius Announces Enrollment Of First Patient In The Mino-Lok™ Phase 3 Trial
Feb 13, 2018 08:00AM Citius Publishes Expert Roundtable Discussion On Treatment Considerations For Catheter Related Bacteremias
Jan 31, 2018 08:00AM Citius Pharmaceuticals to Present at BIO CEO & Investor Conference
Jan 4, 2018 08:00AM Citius Pharmaceuticals to Present at Biotech Showcase™ 2018
Dec 18, 2017 08:02AM Citius Pharmaceuticals (CTXR) Announces 1.28M Share Common Offering at $4.69/Sh
Dec 18, 2017 08:00AM Citius Announces $6 Million Registered Direct Offering Priced At-the-Market
Dec 4, 2017 01:36PM Citius Pharmaceuticals to Present at the 10th Annual LD Micro Invitational
Oct 31, 2017 08:00AM Citius Pharmaceuticals, Inc. Receives "Fast Track" Designation By FDA For Mino-Lok™ Investigational Trial
Oct 17, 2017 09:00AM Citius Pharmaceuticals to Present at the Dawson James 2017 Small Cap Growth Stock Conference
Oct 11, 2017 09:04AM Citius Pharmaceuticals (CTXR) Discusses Recent developments, Financial Results in Shareholder Letter
Oct 11, 2017 09:00AM Citius Pharmaceuticals Issues Shareholder Letter
Sep 18, 2017 02:03PM Citius Pharmaceuticals (CTXR) Halted on LUDP
Sep 5, 2017 07:01AM Citius Pharmaceuticals (CTXR) Reports Phase 3 Update On Mino-Lok Clinical Trial Following FDA Meeting
View More Recent Stories View Older Stories